Literature DB >> 27010419

Neuraminidase inhibition of Dietary chlorogenic acids and derivatives - potential antivirals from dietary sources.

Mohamed Gamaleldin Elsadig Karar1, Marius-Febi Matei1, Rakesh Jaiswal1, Susanne Illenberger1, Nikolai Kuhnert1.   

Abstract

Plants rich in chlorogenic acids (CGAs), caffeic acids and their derivatives have been found to exert antiviral effects against influenza virus neuroaminidase. In this study several dietary naturally occurring chlorogenic acids, phenolic acids and derivatives were screened for their inhibitory activity against neuroaminidases (NAs) from C. perfringens, H5N1 and recombinant H5N1 (N-His)-Tag using a fluorometric assay. There was no significant difference in inhibition between the different NA enzymes. The enzyme inhibition results indicated that chlorogenic acids and selected derivatives, exhibited high activities against NAs. It seems that the catechol group from caffeic acid was important for the activity. Dietary CGA therefore show promise as potential antiviral agents. However, caffeoyl quinic acids show low bioavailibility and are intensly metabolized by the gut micro flora, only low nM concentrations are observed in plasma and urine, therefore a systemic antiviral effect of these compounds is unlikely. Nevertheless, gut floral metabolites with a catechol moiety or structurally related dietary phenolics with a catechol moiety might serve as interesting compounds for future investigations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27010419     DOI: 10.1039/c5fo01412c

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  7 in total

1.  Magnetic beads-based neuraminidase enzyme microreactor as a drug discovery tool for screening inhibitors from compound libraries and fishing ligands from natural products.

Authors:  Yu-Mei Zhao; Lv-Huan Wang; Si-Fan Luo; Qi-Qin Wang; Ruin Moaddel; Ting-Ting Zhang; Zheng-Jin Jiang
Journal:  J Chromatogr A       Date:  2018-07-06       Impact factor: 4.759

2.  Comparative Study on the Antivirus Activity of Shuang-Huang-Lian Injectable Powder and Its Bioactive Compound Mixture against Human Adenovirus III In Vitro.

Authors:  Qinhai Ma; Dedong Liang; Shuai Song; Qintian Yu; Chunyu Shi; Xuefeng Xing; Jia-Bo Luo
Journal:  Viruses       Date:  2017-04-12       Impact factor: 5.048

3.  Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase.

Authors:  Yue Ding; Zeyu Cao; Liang Cao; Gang Ding; Zhenzhong Wang; Wei Xiao
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

Review 4.  Potential Natural Products Against Respiratory Viruses: A Perspective to Develop Anti-COVID-19 Medicines.

Authors:  Marzieh Omrani; Mohsen Keshavarz; Samad Nejad Ebrahimi; Meysam Mehrabi; Lyndy J McGaw; Muna Ali Abdalla; Parvaneh Mehrbod
Journal:  Front Pharmacol       Date:  2021-02-17       Impact factor: 5.810

5.  Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology.

Authors:  Huihui Su; Guosong Wu; Lulu Zhan; Fei Xu; Huiqin Qian; Yanling Li; Ximei Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-08       Impact factor: 2.629

6.  Effects of Dietary Chlorogenic Acid Supplementation Derived from Lonicera macranthoides Hand-Mazz on Growth Performance, Free Amino Acid Profile, and Muscle Protein Synthesis in a Finishing Pig Model.

Authors:  Wenlong Wang; Fengna Li; Yehui Duan; Qiuping Guo; Lingyu Zhang; Yuhuan Yang; Yunju Yin; Mengmeng Han; Saiming Gong; Jianzhong Li; Shanping He; Yulong Yin
Journal:  Oxid Med Cell Longev       Date:  2022-03-12       Impact factor: 6.543

7.  Bioassay-Guided Fractionation of Erythrostemon yucatanensis (Greenm.) Gagnon & GP Lewis Components with Anti-hemagglutinin Binding Activity against Influenza A/H1N1 Virus.

Authors:  Tania Ortiz-López; Rocío Borges-Argáez; Guadalupe Ayora-Talavera; Ernesto Canto-Ramírez; Lisseth Cetina-Montejo; Ángel May-May; Fabiola Escalante-Erosa; Mirbella Cáceres-Farfán
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.